Related Experiment Video
Updated: Jul 4, 2025

A Neonatal Rodent Model of Retroorbital Vein Injection
Published on: February 23, 2024
Pharmacokinetic and pharmacodynamic principles: unique considerations for optimal design of neonatal clinical trials
Cindy Hoi Ting Yeung1, Ruud H J Verstegen1,2, Rachel Greenberg3,4
1Division of Clinical Pharmacology and Toxicology, The Hospital for Sick Children, Toronto, ON, Canada.
Abstract:
Core clinical pharmacology principles must be considered when designing and executing neonatal clinical trials. In this review, the authors discuss important aspects of drug dose selection, pharmacokinetics, pharmacogenetics and pharmacodynamics that stakeholders may consider when undertaking a neonatal or infant clinical trial.
Related Concept Videos
Pharmacodynamics: Overview and Principles
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
Factors Affecting Drug Response: Overview
Nonlinear Pharmacokinetics: Overview
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinear Pharmacokinetics: Role of Transporters
Polymorphisms occurring in drug transporters can alter...
Analysis of Population Pharmacokinetic Data
Biopharmaceutics and Pharmacokinetics: Overview

